HealthEquity (HQY) Tops Q4 EPS by 7c, Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.63, $0.07 better than the analyst estimate of $0.56. Revenue for the quarter came in at $262.4 million versus the consensus estimate of $258.31 million.

GUIDANCE:

HealthEquity sees FY2025 EPS of $2.79-$2.96, versus the consensus of $2.84. HealthEquity sees FY2025 revenue of $1.14-1.16 billion, versus the consensus of $1.15 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance